The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.
Amara CS, Kami Reddy KR, Yuntao Y, Chan YS, Piyarathna DWB, Dobrolecki LE, Shih DJH, Shi Z, Xu J, Huang S, Ellis MJ, Apolo AB, Ballester LY, Gao J, Hansel DE, Lotan Y, Hodges HC, Lerner SP, Creighton CJ, Sreekumar A, Zheng WJ, Msaouel P, Kavuri SM, Putluri N.
Amara CS, et al. Among authors: zheng wj.
Nat Commun. 2024 Feb 14;15(1):1373. doi: 10.1038/s41467-024-45132-2.
Nat Commun. 2024.
PMID: 38355560
Free PMC article.